Effects of the acute myeloid leukemia-associated fusion proteins on nuclear architecture

Seminars in Hematology

Volumn 38, Issue 1, 2001, Pages 42-53

  Faretta, Mario ^a   Di Croce, Luciano ^a   Pelicci, Pier Giuseppe ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; HYBRID PROTEIN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CHEMICAL STRUCTURE; CHIMERA; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE CONTROL; GENE TARGETING; HEMATOPOIESIS; LEUKEMOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0035145329     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(01)90005-8     Document Type: Article

References (83)

1. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and bSNF5/INI1 proteins
2. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
3. Spatial associations of centromeres in the nuclei of hematopoietic cells: Evidence for cell-type-specific organizational patterns
4. The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development
5. Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells
6. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA
7. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm
8. Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb
9. A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest
10. The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation
11. Scaffold attachments within the human genome
12. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins
13. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein
14. MII rearrangements in haematological malignancies: Lessons from clinical and biological studies
15. Tumorigenesis in mice with a fusion of the leukaemia oncogene MLL and the bacterial lacZ gene
16. Human T-cell leukemia retrovirus-Tax protein is a repressor of nuclear receptor signaling
17. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure
18. The disruption of ND1O during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms
19. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO
20. Molecular genetics of human leukemia
21. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukemia
22. Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development
23. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL
24. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications
25. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors
26. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia
27. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1
28. Groucho/TLE/Resp proteins associate with the nuclear matrix and repress RUNX (CBF(α)/AML/PEBP2(α)) dependent activation of tissue-specific gene transcription
29. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells
30. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation
31. Distribution of ABL and BCR genes in cell nuclei of normal and irradiated lymphocytes
32. Active and inactive genes localize preferentially in the periphery of chromosome territories
33. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
34. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors
35. Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers
36. Role of the histone deacetylase complex in acute promyelocytic leukemia
37. p21WAF-1 reorganizes the nucleus in tumor suppression
38. Spatial and temporal dynamics of DNA replication sites in mammalian cells
39. Association of chromosome territories with the nuclear matrix. Disruption of human chromosome territories correlates with the release of a subset of nuclear matrix proteins
40. Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia
41. The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor
42. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
43. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation
44. Retinoid receptors in health and disease: Co-regulators and the chromatin connection
45. PML, a growth suppressor disrupted in acute promyelocytic leukemia
46. Chromosomes exhibit preferential positioning in nuclei of quiescent human cells
47. Mapping replicational sites in the eucaryotic cell nucleus
48. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization
49. The nuclear topography of ABL, BCR, PML, and RARalpha genes: Evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation
50. Alterations of p16 and p15 genes in acute leukemia with MLL gene rearrangements and their correlation with clinical features
51. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
52. Factor-specific modulation of CREB-binding protein acetyltransferase activity
53. Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1
54. Regional and temporal specialization in the nucleus: A transcriptionally-active nuclear domain rich in PTF, Oct1 and PIKA antigens associates with specific chromosomes early in the cell cycle
55. PML induces a novel caspase-independent death process
56. Regulation of chromatin structure by site-specific histone H3 methyltransferases
57. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner
58. Specific staining of human chromosomes in Chinese hamster x man hybrid cell lines demonstrates interphase chromosome territories
59. The PML nuclear bodies: Actors or extras?
60. Involvement of the MLL and RARalpha genes in a patient with acute monocytic leukemia with t(11; 17)(q23;q12)
61. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX
62. Core-binding factor: A central player in hematopoiesis and leukemia
63. Developments in cytogenetics and oncogenes in acute leukemia
64. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins
65. Transcription factors, normal myeloid development, and leukemia
66. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter
67. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein
68. Spatial relationship between transcription sites and chromosome territories
69. Chromosomes as well as chromosomal subdomains constitute distinct units in interphase nuclei
70. CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus
71. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/ mSin3/HDAC1 complex
72. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner
73. PML is essential for multiple apoptotic pathways
74. Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia
75. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation
76. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis
77. Altered Hox expression and segmental identity in MLL-mutant mice
78. 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene
79. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors
80. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation
81. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis
82. Evidence for a nuclear compartment of transcription and splicing located at chromosome domain boundaries
83. Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies